Monitoring the latest Precision Oncology Market Trends reveals a clear trajectory toward non-invasive testing and enhanced data intelligence. The most pronounced trend is the explosive growth and clinical acceptance of Liquid Biopsy. This non-invasive diagnostic method, which uses blood to detect Circulating Tumor DNA (ctDNA) or Circulating Tumor Cells (CTCs), is transforming cancer monitoring,...